Will Syringaresinol significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)
7
24
Ṁ299Ṁ121
resolved Jan 1
Resolved
NO1D
1W
1M
ALL
...treatments that can decelerate the rate of aging are the only available path to significantly increase human lifespan going forward. Before drugs and treatments can be considered for larger clinical studies in humans, pilot trials in rodents must be performed as a necessary prerequisite. This is why the National Institute on Aging established the Interventions Testing Program which “is a multi-institutional study investigating treatments with the potential to extend lifespan and delay disease and dysfunction in mice”.
So far it is the largest systematic effort to test potentially life-extending compounds in mice that has been performed. This is an attempt to give the biogerontology community, interested experts and laypeople an opportunity to predict outcomes of this important experiment.
See also: http://biogerontolgy.blogspot.com/2022/02/a-prediction-market-for-nias-mouse.html
Get Ṁ200 play money
🏅 Top traders
| # | Name | Total profit |
|---|---|---|
| 1 | Ṁ27 | |
| 2 | Ṁ10 | |
| 3 | Ṁ0 |
Sort by:
Recommended resolution: No
See tables 2 & 3 plus the overall results here: https://onlinelibrary.wiley.com/doi/10.1111/acel.13724.
Related questions
Will a senolytic drug be used clinically to slow, prevent, or reverse aging by the end of 2033?
43% chance
Will the Robust Mouse Rejuvenation Study by the LEVF succeed in increasing mouse lifespan 12 months?
40% chance
Will any molecule be shown to extend longevity in the ITP program in 2024?
48% chance
Will Aubrey de Grey's 2022 Robust Mouse Rejuvenation Project "succeed" in its aims of finding an intervention that increases both mean and maximum lifespan of mice by at least 12 months?
38% chance
By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?
Will the pre-clinical results on the cancer drug AOH1996 be broadly confirmed by independent team(s)?
26% chance
Will a senolytic drug be used clinically for any purpose by the end of 2028?
48% chance
Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?
70% chance
Will a scientific discovery extend human lifespan by more than 10 years within the next 20 years?
32% chance
Will any company successfully develop a therapeutic treatment that rejuvenates healthspan by at least 10 years by 2030?
20% chance